Physical Activity and the Pandemic Survey
Has your activity changed since the start of the pandemic?
Research
Tysabri Injections licensed in Europe
The MHRA (Medicines and Healthcare products Regulatory Agency) and European Commission have granted marketing authorisation for an under-the-skin injection of Tysabri. Tysabri is a disease-modifying therapy for highly active relapsing-remitting MS.
Octopus Trial for progressive MS
UK experts are set to run a multi-arm, multi-stage trial which will test a range of drugs already approved for other illnesses for the treatment of multiple sclerosis (MS). The ‘Octopus trial’ will allow three drugs to be tested at the same time.
Launch of All-Ireland MS Research Network
All-Ireland MS Research Network (AIMS-RN) provides hope to those affected by multiple sclerosis
Participating in PPI
Lauren McCauley, person living with MS, patient advisor and a participant
The Impact of COVID-19 on the COB-MS trial
Conducting research remotely by Fionnuala Rogers, Research Assistant at NUI Galway with the COB-MS feasibility trial.
The value of involving PPI in MS research
A case study of anxiety in MS by Dr Rebecca Maguire - Associate Professor, Department of Psychology, Maynooth University
Thinking and Memory Research Study
Researchers at Trinity College Dublin and Beaumont Hospital are carrying out a study exploring cognitive changes (thinking and memory) in Multiple Sclerosis.